SCHEMBL23623802

SCHEMBL23623802

CNOc1ccc2c(-c3ccc(OC)cc3C)c3ccc(=O)cc-3oc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
CYP1A2 P05177 1/20 0.45
KDM4E B2RXH2 6/20 0.44
ALDH1A1 P00352 6/20 0.44
HPGD P15428 4/20 0.44
HSD17B10 Q99714 4/20 0.44
MAOB P27338 3/20 0.43
MAPT P10636 3/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
GAA P10253 2/20 0.42
APP P05067 1/20 0.42
TNKS O95271 1/20 0.41
CYP19A1 P11511 1/20 0.41
USP2 O75604 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
POLB P06746 2/20 0.41
ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16808265 0.92 ALDH1A1 (0.51) CYP2C9CYP2C19CYP1A2KDM4EALDH1A1
SCHEMBL18504843 0.86 MAOB (0.49) CYP2C9CYP2C19CYP1A2KDM4EALDH1A1
SCHEMBL12909280 0.84 MEN1 (0.59) CYP2C9CYP2C19CYP1A2KDM4EALDH1A1
SCHEMBL12909298 0.83 STS (0.44) CYP2C9CYP2C19CYP1A2KDM4EALDH1A1
SCHEMBL15390246 0.83 KMT2A (0.48) CYP2C9CYP2C19CYP1A2KDM4EALDH1A1
SCHEMBL18947824 0.83 KDM4E (0.47) CYP2C9CYP2C19CYP1A2KDM4EALDH1A1
SCHEMBL12909311 0.82 CYP1A2 (0.43) CYP2C9CYP2C19CYP1A2KDM4EALDH1A1
SCHEMBL12909312 0.81 CYP2C9 (0.42) CYP2C9CYP2C19CYP1A2KDM4EALDH1A1
SCHEMBL12909314 0.81 CYP1A2 (0.42) CYP2C9CYP2C19CYP1A2KDM4EALDH1A1
SCHEMBL12909299 0.80 CYP2C9 (0.41) CYP2C9CYP2C19CYP1A2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210207188-A1 BETA-LACTAM COMPOUNDS AND METHODS OF USE THEREOF THE UNIVERSITY OF HONG KONG (HK) 2021-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210207188-A1 BETA-LACTAM COMPOUNDS AND METHODS OF USE THEREOF MGAM, SI, PGLS CYP2C9 510/4885CYP2C19 661/4885CYP1A2 1707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.